Stay informed about the latest developments, announcements, and milestones from the CEO Roundtable on Cancer.
The CEO Roundtable on Cancer appoints Dr. W. Kimryn “Kim” Rathmell, CEO of The Ohio State University Comprehensive Cancer Center, and Dr. Sunil Verma, SVP and Global Head of Oncology at AstraZeneca, to its Life Sciences Council to accelerate therapeutic innovation.
Read Press Release →The CEO Roundtable on Cancer and its independent, not-for-profit initiative Project Data Sphere announce a significant milestone in immuno-oncology research achieved through the Global Oncology Big Data Alliance.
Read Press Release →The CEO Roundtable on Cancer presents the Robert A. Ingram Spirit of Health Award, honoring individuals and organizations that focus on the health of those disproportionately affected by cancer.
Read Press Release →The CEO Roundtable on Cancer announces the appointment of Sean Khozin, MD, MPH, as its next chief executive, sharpening the organization’s focus on AI in cancer research and care.
Read Press Release →The University of North Carolina Pembroke and The University of Texas Permian Basin are the latest minority-serving institutions to join the Going for Gold initiative, expanding equitable cancer care to underserved communities.
Read Press Release →Peter Guenter, member of the Executive Board of Merck and CEO of Healthcare, is unanimously elected to the Board of the CEO Roundtable on Cancer.
Read Press Release →A new report reveals that 56% of people of color live in carcinogenic environments. CEORT and the National Minority Quality Forum announce a public-private collaboration to address the problem.
Read Press Release →Project Data Sphere partners with Qure.ai, a leader in artificial intelligence solutions, to advance AI-enabled diagnostic imaging and democratize access to vital diagnostic services in underserved regions.
Read Press Release →Brand Institute, the global leader in pharmaceutical name development, and Outcomes4Me, an AI-powered patient empowerment platform, are the latest organizations to join the Roundtable’s mission to ease the burden of cancer.
Read Press Release →The CEO Roundtable on Cancer and the National Minority Quality Forum join forces to bring President Biden’s Cancer Moonshot to communities marginalized by discrimination and poverty through the Cancer Stage Shifting Initiative.
Read Press Release →Representatives from universities around the country gathered to discuss how to reduce the burden of cancer at their institutions and in their communities through the Going for Gold initiative.
Elligo Health Research, Black Diamond Therapeutics, Change Healthcare, Jasper Health, and B&C International join the CEO Roundtable on Cancer as new member organizations committed to cancer prevention and treatment.
Read Press Release →The CEO Roundtable on Cancer launches the Going for Gold initiative in partnership with HBCUs, HSIs, and companies including Amgen, Merck, and SAS, with the capacity to impact more than 20 million lives within 7–10 years.
Read Press Release →The US Food and Drug Administration reaffirms its Public-Private Partnership with Project Data Sphere, focusing on their data sharing platform, the irAE program, and autoRECIST to advance cancer research.
Project Data Sphere, LLC announces new executive appointments to strengthen its leadership team and further its mission of providing open access to de-identified patient-level cancer data from clinical trials.
For media inquiries, interview requests, or press materials, please contact our communications team.